Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

NCT05265234 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Eczema
Atopic Dermatitis

Interventions

DRUG: Dupilumab
DEVICE: Optical Coherence Tomography
DEVICE: Reflectance confocal microscopy

Sponsor

OptiSkin Medical

Collaborators

[object Object]